Appointment of Dr Ian Gilham to the Board of Directors of Novacyt

Novacyt, a leading molecular diagnostics company, announces the appointment of Dr Ian Gilham as a non-executive director. The appointment, effective immediately, requires shareholder approval at the Annual General Meeting. With a distinguished career In the life sciences sector, Ian Gilham brings valuable expertise to the Novacyt Board.

Currently Non-Executive Chairman of Genedrive PLC and LifeArc, Dr Gilham has extensive experience in the research and commercialisation of diagnostic products. He has held positions in several AIM-listed companies, strengthening the strategic expertise of Novacyt. Novacyt CEO Lyn Rees expressed his satisfaction with the arrival of Ian Gilham, highlighting the considerable contribution of his expertise to the group.